AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $11,064,000 | +7.1% | 793,712 | 0.0% | 0.10% | -25.4% |
| Q3 2020 | $10,334,000 | -25.4% | 793,712 | 0.0% | 0.13% | -33.3% |
| Q2 2020 | $13,850,000 | +34.2% | 793,712 | +19.7% | 0.20% | +12.7% |
| Q1 2020 | $10,319,000 | -19.2% | 663,174 | +4.5% | 0.17% | -4.9% |
| Q4 2019 | $12,777,000 | +58.6% | 634,700 | +11.2% | 0.18% | +19.0% |
| Q3 2019 | $8,058,000 | +367.4% | 570,700 | +438.4% | 0.15% | +466.7% |
| Q2 2019 | $1,724,000 | -60.6% | 106,000 | -46.6% | 0.03% | -60.3% |
| Q1 2019 | $4,379,000 | +5.2% | 198,583 | -20.5% | 0.07% | -11.7% |
| Q4 2018 | $4,161,000 | -67.9% | 249,900 | -0.0% | 0.08% | -50.6% |
| Q3 2018 | $12,968,000 | +81.6% | 250,000 | 0.0% | 0.16% | +83.5% |
| Q2 2018 | $7,140,000 | – | 250,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
| Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
| Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
| Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
| EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
| Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
| MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |